Lantheus Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-12-31 was 0.00 shares.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-09-30 was 0.00 shares.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 171.10K shares, a 18.39% decline from fiscal 2024.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 209.66K shares, a 2.31% decline from fiscal 2023.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 214.62K shares, a 46.05% decline from fiscal 2022.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 397.82K shares, a 24.84% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 171.10K shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 209.66K shares 10-K · filed 2026-02-26 | |
| 2023-12-31 | 214.62K shares 10-K · filed 2026-02-26 | |
| 2022-12-31 | 397.82K shares 10-K · filed 2025-02-26 | |
| 2021-12-31 | 318.66K shares 10-K · filed 2024-02-22 | |
| 2020-12-31 | 8.87K shares 10-K · filed 2023-02-23 | |
| 2019-12-31 | 67.56K shares 10-K · filed 2022-02-24 | |
| 2018-12-31 | 192.55K shares 10-K · filed 2021-02-25 | |
| 2017-12-31 | 465.23K shares 10-K · filed 2020-02-25 | |
| 2016-12-31 | 40.98K shares 10-K · filed 2019-02-20 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | 0.00 shares 10-K · filed 2018-02-26 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |